New Zealand - English - Medsafe (Medicines Safety Authority)

adiramedica pty ltd. - levetiracetam 250mg;   - film coated tablet - 250 mg - active: levetiracetam 250mg   excipient: copovidone croscarmellose sodium magnesium stearate opadry blue opadry clear oy-29020 pregelatinised maize starch purified talc purified water - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

adiramedica pty ltd. - levetiracetam 500mg;   - film coated tablet - 500 mg - active: levetiracetam 500mg   excipient: copovidone croscarmellose sodium magnesium stearate opadry clear oy-29020 opadry yellow pregelatinised maize starch purified talc purified water - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

adiramedica pty ltd. - levetiracetam 750mg;   - film coated tablet - 750 mg - active: levetiracetam 750mg   excipient: copovidone croscarmellose sodium magnesium stearate opadry clear oy-29020 opadry orange pregelatinised maize starch purified talc purified water - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).